NCT01920542

Dexmedetomidine on Pediatric Heart Operation

Renal Effects of Dexmedetomidine During Pediatric Cardiac Surgery: a Randomized Placebo-controlled Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Gachon University Gil Medical Center · Academic / Other
• Sex: All
• Age: 1 Year – 6 Years
• Healthy volunteers: Not accepted

Summary

we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients

Detailed description

dexmedetomidine, a2-adrenoreceptor agonist has been used for sedation or hemodynamic stability for operative procedure. It had been already reported that dexmedetomidine reduce the impairment of renal functon after cardiac operation in adult. we hypothized dexmedetomidine could reduce the reduction of renal function after cardiopulmonary bypass weaning in pediatric patients

Conditions

• Acute Renal Injury

Interventions

Type	Name	Description
DRUG	Dexmedetomidine	administration of dexmedetomidine on dexemedetomidine group
DRUG	no dexmedetomidine	no administration of dexmedetomidine on control group

Timeline

• Start date: 2013-09-01
• Primary completion: 2016-07-01
• Completion: 2016-08-01
• First posted: 2013-08-12
• Last updated: 2016-11-10

Locations

1 site across 1 country: South Korea